Percutaneous transluminal renal sympathetic denervation for resistant hypertension

Preliminary market consultation to inform the NHS commercial strategy for percutaneous transluminal renal sympathetic denervation for resistant hypertension. Please note all stated financial values in relation to this notice are nominal, as the financial envelope is yet to be defined. Projected contracting dates in the notice, similarly do not reflect any plans as these are yet to be defined. To express interest, review and respond to the request for information questionnaire please register and apply via Atamis e-...